Drugs

Metabolic Profile of Nebivolol, a β-Adrenoceptor Antagonist with Unique Characteristics
pp. 1097-1107(11)
Authors: Enrico Agabiti Rosei,; Rizzoni, Damiano

Hormone-Refractory Prostate Cancer: Where are We Going?
pp. 1109-1124(16)
Authors: Giuseppe Di Lorenzo,; Autorino, Riccardo; Figg, William D.; Sabino De Placido,

Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
pp. 1125-1138(14)
Author: Dancey, Janet E.

Guidelines for the Use of Corticosteroids in the Treatment of Pulmonary Sarcoidosis
pp. 1139-1147(9)
Author: Coker, Robina K.

Management Options for Malignant Pleural Mesothelioma: Clinical and Cost Considerations
pp. 1149-1165(17)
Author: Goudar, Ranjit K.

Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients: A Systematic Review
pp. 1167-1198(32)
Authors: Gutierrez-Dalmau, Alex; Campistol, Josep M.

Ranibizumab
pp. 1199-1206(8)
Authors: Blick, Stephanie K.A.; Keating, Gillian M.; Wagstaff, Antona J.

Ranibizumab: A Viewpoint by Steven D. Schwartz
pp. 1207-1209(3)
Author: Schwartz, Steven D.

Ranibizumab: A Viewpoint by Thomas A. Ciulla
pp. 1207-1209(3)
Author: Ciulla, Thomas A.

Ranibizumab: A Viewpoint by Winfried Amoaku
pp. 1207-1209(3)
Author: Amoaku, Winfried

Etanercept: A Review of its Use in the Management of Rheumatoid Arthritis
pp. 1211-1241(31)
Authors: Dhillon, Sohita; Lyseng-Williamson, Katherine A.; Scott, Lesley J.